Abstract
Thalidomide has recently been employed as a single agent and in combination chemotherapy for experimental treatment relapsed or refractory multiple myeloma and as a first line treatment. A new complication has emerged: a thalidomide-induced hypercoagulable state. We report on 5 patients who developed deep vein thrombosis of the lower limbs while on thalidomide and chemotherapy. The biological mechanism underlying this complication is unknown and appears to be worsened by the association with dexamethasone and/or chemotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 1108-1109 |
| Number of pages | 2 |
| Journal | Haematologica |
| Volume | 86 |
| Issue number | 10 |
| Publication status | Published - 2001 |
Keywords
- Multiple myeloma
- Thalidomide
- Thrombosis
ASJC Scopus subject areas
- Hematology